The L3Harris Next Generation Aiming Laser (NGAL) (NGL-000-A1) is a rugged, ultra-compact and lightweight system designed to be compatible with all generations of night vision devices.

Neutrophil gelatinase-associated lipocalin (NGAL) is a 25 kDa protein belonging to the lipocalin superfamily. It was initially found in activated neutrophils, however, many other cells, like …

The size of a credit card, NGAL uses an advanced illuminator design to achieve a more uniform near infrared illuminator beam for increased situational awareness. High-efficiency electronics …

The L3Harris NGAL is a rugged, ultra-compact and lightweight system designed to be compatible with all generations of night vision devices. NGAL uses an advanced illuminator design to …

Neutrophil gelatinase-associated lipocalin (NGAL) is an emerging biomarker for the early detection of AKI. Studies have shown NGAL to be a highly induced protein in the kidney after …

NGAL is produced in the distal nephron and its synthesis is up-regulated in response to kidney injury. NGAL is an ion-transporting agent. Markers of damage are potentially better than …

Urinary neutrophil gelatinase-associated lipocalin (NGAL) has shown promise in differentiating acute tubular necrosis (ATN) from other types of acute kidney injuries (AKIs) in cirrhosis, …

Lipocalin-2 (NGAL) is typically assessed for clinical or research purposes using ELISA or immunoturbidimetric assays. Lipocalin-2 (NGAL) was approved by the US FDA (Dec 7, 2023) …

Neutrophil gelatinase-associated lipocalin (NGAL), a 25 kDa protein produced by injured nephron epithelia, is one of the most promising new markers of renal epithelial injury. In contrast to …

The evidence for the role of NGAL measurements in a variety of clinical situations leading to AKI (cardiac surgery, kidney transplantation, contrast nephropathy, haemolytic uraemic syndrome …